New hope for kids with leukemia: testing a powerful drug combo
NCT ID NCT05955261
Summary
This study is testing whether adding a drug called venetoclax to standard chemotherapy is safe and effective for children and young adults with newly diagnosed acute myeloid leukemia (AML). It will involve about 70 participants under 22 years old. The main goals are to see if the combination is tolerable and if it can drive the cancer down to very low levels after the first round of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Orange County
Orange, California, 92868, United States
-
Children's National Medical Center
Washington D.C., District of Columbia, 20020, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Cook Children's Medical Center
Fort Worth, Texas, 76104, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Novant Health Presbyterian Medical Center
Charlotte, North Carolina, 28204, United States
-
Rady Children's Hospital-San Diego
San Diego, California, 92123, United States
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
Valley Children's Hospital
Madera, California, 93636, United States
Conditions
Explore the condition pages connected to this study.